Related Experiment Video
Updated: Dec 12, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
[COVID-19 and the impact of cardiovascular comorbidities]
1Universitätsklinikum Schleswig-Holstein, Campus Kiel, Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin.
Insights
Coronavirus disease 2019 (COVID-19) significantly impacts cardiovascular health, increasing mortality risk. Continued cardiovascular disease (CVD) treatment is crucial during the pandemic to prevent worse outcomes.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Coronavirus disease 2019 (COVID-19) is a global pandemic with significant cardiovascular implications.
- Pre-existing cardiovascular disease (CVD) is linked to severe COVID-19 and increased mortality.
- COVID-19 can lead to acute cardiovascular syndromes, even with initial respiratory symptoms.
Purpose of the Study:
- To review the cardiovascular impact of COVID-19.
- To discuss the role of angiotensin-converting enzyme 2 in COVID-19's cardiovascular effects.
- To provide guidance on managing cardiovascular conditions during the pandemic.
Main Methods:
- Literature review of studies on COVID-19 and cardiovascular disease.
- Analysis of the role of the renin-angiotensin-aldosterone system in COVID-19.
- Discussion of clinical management strategies and ongoing research.
Main Results:
- Angiotensin-converting enzyme 2 is a key link between COVID-19 and the cardiovascular system.
- No evidence suggests harm from renin-angiotensin-aldosterone-system inhibitors in COVID-19 patients.
- Potential cardiotoxicity of investigational drugs is a concern.
- COVID-19 may cause long-term cardiovascular damage.
Conclusions:
- Continue renin-angiotensin-aldosterone-system inhibitor therapy for patients with hypertension or heart failure.
- Ensure timely treatment of acute cardiovascular disease and adherence to guideline-directed therapy.
- A long-term management strategy is necessary for patients with potential long-term cardiovascular damage from COVID-19.
Abstract:
Since its outbreak, coronavirus disease 2019 (COVID-19) has rapidly resulted in a global pandemic. Underlying cardiovascular disease (CVD) is associated with severe COVID-19 infection and adverse clinical outcomes. While COVID-19 predominantly causes respiratory symptoms, a substantial number of patients eventually develop an acute cardiovascular syndrome associated with an excessive risk of mortality. While the exact mechanisms remain uncertain, angiotensin-converting enzyme 2 plays a pivotal role as a link between COVID-19 and the cardiovascular system. As there is no evidence that inhibition of the renin-angiotensin-aldosterone-system is harmful in COVID-19, therapy should be continued as indicated in hypertension or heart failure patients. As multiple drugs are being investigated in ongoing clinical trials, potential cardiotoxicity remains an important issue. In times of rigorous public health measures such as social distancing, efforts should be undertaken to ensure timely treatment of acute CVD and continuation of guideline-directed treatment in order to avoid an increase in morbidity and mortality. In addition to its acute complications, COVID-19 is likely to be associated with long-term cardiovascular damage. Consequently, for a subgroup of patients a long-term management strategy is needed.
More Related Videos
Related Concept Videos
Coronary Artery Disease I: Introduction
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Coronary Artery Disease III: Clinical Manifestations

